[Federal Register Volume 80, Number 163 (Monday, August 24, 2015)]
[Notices]
[Page 51278]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-20820]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2015-N-0001]
Science Board to the Food and Drug Administration; Notice of
Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public, via Webcast.
Name of Committee: Science Board to the Food and Drug
Administration (Science Board).
General Function of the Committee: The Science Board provides
advice to the Commissioner of Food and Drugs and other appropriate
officials on specific, complex scientific and technical issues
important to the FDA and its mission, including emerging issues within
the scientific community. Additionally, the Science Board provides
advice to the Agency on keeping pace with technical and scientific
developments including in regulatory science, input into the Agency's
research agenda, and on upgrading its scientific and research
facilities and training opportunities. It will also provide, where
requested, expert review of Agency sponsored intramural and extramural
scientific research programs.
Date and Time: The meeting will be held on September 15, 2015, from
4 p.m. until 5:30 p.m.
Location: This meeting will take place via Webcast. To access the
link for the Webcast check the Agency's Web site at http://www.fda.gov/AdvisoryCommittees/default.htm and scroll down to the appropriate
advisory committee meeting link. Information regarding special
accommodations due to a disability may be accessed at http://www.fda.gov/AdvisoryCommittees/default.htm.
Contact Person: Rakesh Raghuwanshi, Office of the Chief Scientist,
Office of the Commissioner, Food and Drug Administration, Bldg. 1, Rm.
3309, 10903 New Hampshire Ave., Silver Spring, MD 20993, 301-796-4769,
[email protected], or FDA Advisory Committee Information
Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area). A
notice in the Federal Register about last minute modifications that
impact a previously announced advisory committee meeting cannot always
be published quickly enough to provide timely notice. Therefore, you
should always check the Agency's Web site at http://www.fda.gov/AdvisoryCommittees/default.htm and scroll down to the appropriate
advisory committee meeting link, or call the advisory committee
information line to learn about possible modifications before coming to
the meeting.
Agenda: The Science Board will be provided with a report from the
Science Looking Forward subcommittee.
FDA intends to make background material available to the public no
later than 2 business days before the meeting. Background material is
available at http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm. Scroll down to the appropriate advisory committee meeting
link.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person on or before
September 8, 2015. Oral presentations from the public will be scheduled
between approximately 4:30 p.m. and 5:30 p.m. Those individuals
interested in making formal oral presentations should notify the
contact person and submit a brief statement of the general nature of
the evidence or arguments they wish to present, the names and addresses
of proposed participants, and an indication of the approximate time
requested to make their presentation on or before September 1, 2015.
Time allotted for each presentation may be limited. If the number of
registrants requesting to speak is greater than can be reasonably
accommodated during the scheduled open public hearing session, FDA may
conduct a lottery to determine the speakers for the scheduled open
public hearing session. The contact person will notify interested
persons regarding their request to speak by September 2, 2015.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Rakesh Raghuwanshi
at least 7 days in advance of the meeting.
FDA is committed to the orderly conduct of its advisory committee
meetings. Please visit our Web site at http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for procedures
on public conduct during advisory committee meetings.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: August 18, 2015.
Jill Hartzler Warner,
Associate Commissioner for Special Medical Programs.
[FR Doc. 2015-20820 Filed 8-21-15; 8:45 am]
BILLING CODE 4164-01-P